Cargando…

A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank

BACKGROUND: Multimorbidities greatly increase the global health burdens, but the landscapes of their genetic risks have not been systematically investigated. METHODS: We used the hospital inpatient data of 385,335 patients in the UK Biobank to investigate the multimorbid relations among 439 common d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Guiying, Feng, Jianfeng, Sun, Fengzhu, Chen, Jingqi, Zhao, Xing-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258962/
https://www.ncbi.nlm.nih.gov/pubmed/34225788
http://dx.doi.org/10.1186/s13073-021-00927-6
_version_ 1783718591505367040
author Dong, Guiying
Feng, Jianfeng
Sun, Fengzhu
Chen, Jingqi
Zhao, Xing-Ming
author_facet Dong, Guiying
Feng, Jianfeng
Sun, Fengzhu
Chen, Jingqi
Zhao, Xing-Ming
author_sort Dong, Guiying
collection PubMed
description BACKGROUND: Multimorbidities greatly increase the global health burdens, but the landscapes of their genetic risks have not been systematically investigated. METHODS: We used the hospital inpatient data of 385,335 patients in the UK Biobank to investigate the multimorbid relations among 439 common diseases. Post-GWAS analyses were performed to identify multimorbidity shared genetic risks at the genomic loci, network, as well as overall genetic architecture levels. We conducted network decomposition for the networks of genetically interpretable multimorbidities to detect the hub diseases and the involved molecules and functions in each module. RESULTS: In total, 11,285 multimorbidities among 439 common diseases were identified, and 46% of them were genetically interpretable at the loci, network, or overall genetic architecture levels. Multimorbidities affecting the same and different physiological systems displayed different patterns of the shared genetic components, with the former more likely to share loci-level genetic components while the latter more likely to share network-level genetic components. Moreover, both the loci- and network-level genetic components shared by multimorbidities converged on cell immunity, protein metabolism, and gene silencing. Furthermore, we found that the genetically interpretable multimorbidities tend to form network modules, mediated by hub diseases and featuring physiological categories. Finally, we showcased how hub diseases mediating the multimorbidity modules could help provide useful insights for the genetic contributors of multimorbidities. CONCLUSIONS: Our results provide a systematic resource for understanding the genetic predispositions of multimorbidities and indicate that hub diseases and converged molecules and functions may be the key for treating multimorbidities. We have created an online database that facilitates researchers and physicians to browse, search, or download these multimorbidities (https://multimorbidity.comp-sysbio.org). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00927-6.
format Online
Article
Text
id pubmed-8258962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82589622021-07-06 A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank Dong, Guiying Feng, Jianfeng Sun, Fengzhu Chen, Jingqi Zhao, Xing-Ming Genome Med Research BACKGROUND: Multimorbidities greatly increase the global health burdens, but the landscapes of their genetic risks have not been systematically investigated. METHODS: We used the hospital inpatient data of 385,335 patients in the UK Biobank to investigate the multimorbid relations among 439 common diseases. Post-GWAS analyses were performed to identify multimorbidity shared genetic risks at the genomic loci, network, as well as overall genetic architecture levels. We conducted network decomposition for the networks of genetically interpretable multimorbidities to detect the hub diseases and the involved molecules and functions in each module. RESULTS: In total, 11,285 multimorbidities among 439 common diseases were identified, and 46% of them were genetically interpretable at the loci, network, or overall genetic architecture levels. Multimorbidities affecting the same and different physiological systems displayed different patterns of the shared genetic components, with the former more likely to share loci-level genetic components while the latter more likely to share network-level genetic components. Moreover, both the loci- and network-level genetic components shared by multimorbidities converged on cell immunity, protein metabolism, and gene silencing. Furthermore, we found that the genetically interpretable multimorbidities tend to form network modules, mediated by hub diseases and featuring physiological categories. Finally, we showcased how hub diseases mediating the multimorbidity modules could help provide useful insights for the genetic contributors of multimorbidities. CONCLUSIONS: Our results provide a systematic resource for understanding the genetic predispositions of multimorbidities and indicate that hub diseases and converged molecules and functions may be the key for treating multimorbidities. We have created an online database that facilitates researchers and physicians to browse, search, or download these multimorbidities (https://multimorbidity.comp-sysbio.org). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-00927-6. BioMed Central 2021-07-05 /pmc/articles/PMC8258962/ /pubmed/34225788 http://dx.doi.org/10.1186/s13073-021-00927-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dong, Guiying
Feng, Jianfeng
Sun, Fengzhu
Chen, Jingqi
Zhao, Xing-Ming
A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title_full A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title_fullStr A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title_full_unstemmed A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title_short A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank
title_sort global overview of genetically interpretable multimorbidities among common diseases in the uk biobank
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258962/
https://www.ncbi.nlm.nih.gov/pubmed/34225788
http://dx.doi.org/10.1186/s13073-021-00927-6
work_keys_str_mv AT dongguiying aglobaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT fengjianfeng aglobaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT sunfengzhu aglobaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT chenjingqi aglobaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT zhaoxingming aglobaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT dongguiying globaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT fengjianfeng globaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT sunfengzhu globaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT chenjingqi globaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank
AT zhaoxingming globaloverviewofgeneticallyinterpretablemultimorbiditiesamongcommondiseasesintheukbiobank